New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
    PubMed
          
           23435200
           
          
          
    DOI
          
           10.1016/j.steroids.2013.02.001
           
          
          
      PII:  S0039-128X(13)00035-4
  
    Knihovny.cz E-zdroje
    
  
              
      
- MeSH
- buněčná membrána účinky léků metabolismus MeSH
- farmakokinetika MeSH
- hydrofobní a hydrofilní interakce MeSH
- intestinální absorpce účinky léků MeSH
- kožní absorpce účinky léků MeSH
- kyseliny cholové chemie farmakologie toxicita MeSH
- léčivé přípravky metabolismus MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- permeabilita účinky léků MeSH
- proliferace buněk účinky léků MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- cholanic acid MeSH Prohlížeč
- kyseliny cholové MeSH
- léčivé přípravky MeSH
A series of final twelve propanoyloxy derivatives of 5β-cholan-24-oic acid (O-propanoyl derivatives of cholic acid) as potential drug absorption modifiers (skin penetration enhancers, intestinal absorption promoters) was generated by multistep synthesis. Structure confirmation of all generated compounds was accomplished by 1H NMR, 13C NMR, IR and MS spectroscopy methods. All the prepared compounds were analyzed using RP-TLC, and their lipophilicity (RM) was determined. The hydrophobicity (log P), solubility (log S), polar surface area (PSA) and molar volume (MV) of the studied compounds were also calculated. All the target compounds were tested for their in vitro transdermal penetration effect and as potential intestinal absorption enhancers. The cytotoxicity of all the evaluated compounds was evaluated against normal human skin fibroblast cells. Their anti-proliferative activity was also assessed against human cancer cell lines: T-lymphoblastic leukemia cell line and breast adenocarcinoma cell line. One compound showed selective cytotoxicity against human skin fibroblast cells and another compound possessed the highest cytotoxicity against all the tested cell lines. Only one compound expressed anti-proliferative effect on leukemia cancer cells without affecting the growth of normal cells, which should be promising in potential development of new drugs. Most of the target compounds showed minimal anti-proliferative activity (IC50>37 μM), indicating they would have moderate cytotoxicity when administered as chemical absorption modifiers. The relationships between the lipophilicity/polarity and the chemical structure of the studied compounds as well as the relationships between their chemical structure and enhancement effect are discussed in this article.
Citace poskytuje Crossref.org
